Arbor Biotechnologies Company
Arbor Biotechnologies is a company that focuses on developing genetic medicines using programmable DNA editors to achieve curative outcomes for patients.
Investors
Founded Date:
2016-01-01
Total Funding:
230600000.0
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Biopharma, Biotechnology, Life Science
Last Funding Type:
Series B
Investors Number:
21.0
Last Funding Date:
2021-11-09
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
$1M to $10M